Cell Source Operating Income Growth & History (CLCS)

Cell Source's operating income was −$3.8M for fiscal 2024.

View full Cell Source company overview

Cell Source annual operating income history

Cell Source annual operating income

Fiscal yearPeriod endedOperating incomeChangeGrowth
20242024-12-31−$3.8M$485,102
20232023-12-31−$4.3M−$150,013
20222022-12-31−$4.2M−$156,761
20212021-12-31−$4.0M−$380,536
20202020-12-31−$3.6M$167,165
20192019-12-31−$3.8M−$1.8M
20182018-12-31−$2.0M$286,660
20172017-12-31−$2.3M

Cell Source operating income trends

Over the last five fiscal years, Cell Source's operating income decreased from −$3.8M to −$3.8M, a change of −$35,043. The latest reported quarter, Q1 2025, shows −$998,587.

About the metric

What operating income means

Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.

Calculation and source

SEC-reported operating income

TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cell Source source filings ↗

Community posts

It’s quiet here.

No posts about CLCS yet. Start the conversation.

Write the first post